News
-
-
-
COMMUNIQUÉ DE PRESSE
Piramal Pharma Solutions Launches New Microbiology Laboratory at Its Lexington, KY Sterile Injectable Facility
Piramal Pharma Solutions launches new microbiology laboratory at its Lexington, KY sterile injectable facility, enhancing capabilities and efficiency as part of a broader expansion to be completed by late 2027 -
-
-
COMMUNIQUÉ DE PRESSE
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
Piramal Pharma Solutions and NP2 are set to complete the development phase of cyclophosphamide, addressing shortages and supply chain risks, ensuring patient access to cancer treatment in the U.S -
-
-
COMMUNIQUÉ DE PRESSE
Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility
Ontario invests $1.7 million in Piramal Pharma's Aurora facility, enhancing healthcare innovation and creating job opportunities. Government supports life sciences sector growth -
